Chlamydia Symptoms in Women: What to Look For and When to Get Tested

Why is chlamydia so easy to miss in women?

Chlamydia is caused by the bacterium *Chlamydia trachomatis* and is among the most commonly reported bacterial infections in the United States. In women, it most often infects the cervix — an internal site that produces no direct sensation. The majority of infections cause little or no noticeable change. When symptoms do appear, they are easy to attribute to something more ordinary: a mild yeast infection, a bladder irritation, or hormonal spotting 1Ref 1Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, Reno H, Zenilman JM, Bolan GA (2021).Sexually Transmitted Infections Treatment Guidelines, 2021.Clinical presentation of chlamydia in women, PID as a complication of untreated infection, neonatal transmission in pregnancy, preferred antibiotics in pregnancy, and retesting recommendations.

Because of this, a substantial proportion of people with chlamydia are unaware they carry it — which is why routine screening matters more than waiting for obvious signs 2Ref 2US Preventive Services Task Force; Davidson KW, Barry MJ, Mangione CM, et al. (2021).Screening for Chlamydia and Gonorrhea: US Preventive Services Task Force Recommendation Statement.Annual screening recommendation for all sexually active women under 25, and for older women with new or multiple partners. Annual chlamydia testing is a key part of preventive care for sexually active women under 25.

What symptoms can appear?

When chlamydia does produce changes, they may include:

• Increased vaginal discharge that appears yellow or cloudy
• A burning or stinging sensation during urination
• Light spotting or bleeding between periods or after sex (postcoital bleeding)
• Mild pelvic discomfort or a sense of pressure in the lower abdomen
• Less commonly, rectal discomfort, discharge, or itching if there was anal exposure

None of these symptoms are exclusive to chlamydia — they overlap substantially with bacterial vaginosis, gonorrhea, urinary tract infections, and trichomoniasis. Only laboratory testing makes the distinction 1Ref 1Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, Reno H, Zenilman JM, Bolan GA (2021).Sexually Transmitted Infections Treatment Guidelines, 2021.Clinical presentation of chlamydia in women, PID as a complication of untreated infection, neonatal transmission in pregnancy, preferred antibiotics in pregnancy, and retesting recommendations.

What are the risks of leaving chlamydia untreated?

Without treatment, chlamydia can spread upward from the cervix into the uterus and fallopian tubes, causing pelvic inflammatory disease (PID). PID can lead to chronic pelvic pain and, in some cases, can affect tubal patency and future fertility. These are serious but preventable consequences — chlamydia responds well to antibiotics when detected promptly 1Ref 1Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, Reno H, Zenilman JM, Bolan GA (2021).Sexually Transmitted Infections Treatment Guidelines, 2021.Clinical presentation of chlamydia in women, PID as a complication of untreated infection, neonatal transmission in pregnancy, preferred antibiotics in pregnancy, and retesting recommendations.

In pregnancy, untreated chlamydia can be transmitted to the newborn during delivery, causing neonatal conjunctivitis or pneumonia. Screening for chlamydia is standard in prenatal care, and certain antibiotics are preferred for treatment during pregnancy to ensure fetal safety 1Ref 1Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, Reno H, Zenilman JM, Bolan GA (2021).Sexually Transmitted Infections Treatment Guidelines, 2021.Clinical presentation of chlamydia in women, PID as a complication of untreated infection, neonatal transmission in pregnancy, preferred antibiotics in pregnancy, and retesting recommendations2Ref 2US Preventive Services Task Force; Davidson KW, Barry MJ, Mangione CM, et al. (2021).Screening for Chlamydia and Gonorrhea: US Preventive Services Task Force Recommendation Statement.Annual screening recommendation for all sexually active women under 25, and for older women with new or multiple partners.

Who should be tested, and how?

Annual screening is recommended for all sexually active women under 25, and for older women with new or multiple partners 2Ref 2US Preventive Services Task Force; Davidson KW, Barry MJ, Mangione CM, et al. (2021).Screening for Chlamydia and Gonorrhea: US Preventive Services Task Force Recommendation Statement.Annual screening recommendation for all sexually active women under 25, and for older women with new or multiple partners. If you have had a new partner, have had unprotected sex, or have any of the symptoms above — or if a partner has been diagnosed — testing now is the right step. You do not need to wait for symptoms.

Testing is done via a vaginal swab (self-collected or clinician-collected) or a urine sample, using a NAAT (nucleic acid amplification test) — the most accurate available method. Chlamydia and gonorrhea are often tested together since they frequently co-occur and are clinically indistinguishable by symptoms alone 1Ref 1Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, Reno H, Zenilman JM, Bolan GA (2021).Sexually Transmitted Infections Treatment Guidelines, 2021.Clinical presentation of chlamydia in women, PID as a complication of untreated infection, neonatal transmission in pregnancy, preferred antibiotics in pregnancy, and retesting recommendations.

Treatment, partner notification, and preventing reinfection

Chlamydia is treatable with a short antibiotic course prescribed by a clinician. The regimen depends on your specific situation, allergies, pregnancy status, and whether co-infection with other organisms is suspected.

Important steps during and after treatment: - Complete the full antibiotic course - Avoid sex during treatment and until all partners have also been treated - Notify recent partners so they can be tested and treated — reinfection is common when partners are not treated concurrently 1Ref 1Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, Reno H, Zenilman JM, Bolan GA (2021).Sexually Transmitted Infections Treatment Guidelines, 2021.Clinical presentation of chlamydia in women, PID as a complication of untreated infection, neonatal transmission in pregnancy, preferred antibiotics in pregnancy, and retesting recommendations - Retesting approximately three months after treatment is recommended to detect reinfection

Prior chlamydia infection does not provide immunity. Routine future screening and consistent condom use are the main tools for ongoing prevention.